open access
Only one step from tailored oncological therapies
open access
Abstract
The personalization of oncological therapy is becoming a reality thanks to the development of molecular biology techniques (e.g. next generation sequencing, liquid biopsy) and the discovery of new molecularly targeted therapies and immunotherapeutics. Genetic laboratories and clinical centers, which form international networks as well as global, early phase clinical trials make it possible to match treatments to a particular patient. The benefit of such a procedure is currently difficult to estimate, but it seems that another path for the development of oncology is not possible.
Abstract
The personalization of oncological therapy is becoming a reality thanks to the development of molecular biology techniques (e.g. next generation sequencing, liquid biopsy) and the discovery of new molecularly targeted therapies and immunotherapeutics. Genetic laboratories and clinical centers, which form international networks as well as global, early phase clinical trials make it possible to match treatments to a particular patient. The benefit of such a procedure is currently difficult to estimate, but it seems that another path for the development of oncology is not possible.
Keywords
oncology, molecularly targeted therapies, immunotherapies, gene sequencing, liquid biopsy
About this articleTitle
Only one step from tailored oncological therapies
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Other materials agreed with the Editors
Pages
42-45
Published online
2018-06-20
Page views
774
Article views/downloads
709
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2018;68(1):42-45.
Keywords
oncology
molecularly targeted therapies
immunotherapies
gene sequencing
liquid biopsy
Authors
Paweł Krawczyk